Key result
The optimal management of pregnancy in women with end-stage kidney disease remains debated, as both intensive hemodialysis and kidney transplantation present unique maternal and fetal risks.
Why the study?
Is there equipoise regarding optimal pregnancy management between intensive hemodialysis and kidney transplantation in women with end-stage kidney disease?
Is there equipoise regarding optimal pregnancy management between intensive hemodialysis and kidney transplantation in women with end-stage kidney disease?
The optimal management of pregnancy in women with end-stage kidney disease remains debated, balancing the risks and benefits of intensive hemodialysis versus kidney transplantation.
The optimal management of pregnancy in women with end-stage kidney disease remains an important and evolving topic of debate.1,2 Historically, kidney transplantation has been viewed as the optimal path to achieving favorable maternal and fetal outcomes through restoration of endocrine and metabolic homeostasis.1–3 However, transplantation carries maternal and fetal risks.2 In addition, lengthy waitlists for deceased donors and limited access to living donation can make transplantation an impractical option for young women wishing to conceive.
No takes yet. Share an insight, caveat, or question.
Arriola‐Montenegro et al. (2025) conducted an editorial in End-stage kidney disease in pregnancy. Intensive hemodialysis versus kidney transplantation was evaluated. The optimal management of pregnancy in women with end-stage kidney disease remains debated, as both intensive hemodialysis and kidney transplantation present unique maternal and fetal risks.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: